FDA Releases Federal Interagency Working Group Scientific Opinions on Testing Methods for Asbestos in Talc-Containing Cosmetic Products

 

Today, the U.S. Food and Drug Administration released a white paper developed by the Interagency Working Group on Asbestos in Consumer Products (IWGACP) that contains scientific opinions for the testing of talc-containing cosmetics and talc intended for use in cosmetics for the possible presence of asbestos, a known human carcinogen with well-documented health risks.… Read full story

Ohio Expands COVID-19 Testing Locations with Support from Ohio National Guard

(COLUMBUS, Ohio) – January 11, 2022 – Ohio Governor Mike DeWine today announced additional Guard deployments to support COVID-19 testing locations across the state, including three testing locations in Cincinnati.

“We are grateful that National Guard members are continuing to fill critical roles in our state’s response to this pandemic, especially as the strain on our health care providers continues,” said Governor DeWine.… Read full story

NIH Researchers Develop First Stem Cell Model of Albinism to Study Related Eye Conditions

Use of patient-derived stem cells will enable high-throughput drug screening for potential therapeutics.

Researchers at the National Eye Institute (NEI) have developed the first patient-derived stem cell model for studying eye conditions related to oculocutaneous albinism (OCA). The model’s development is described in the January issue of the journal Stem Cell Reports.… Read full story

Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months

 

Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Moderna COVID-19 Vaccine to shorten the time between the completion of a primary series of the vaccine and a booster dose to at least five months for individuals 18 years of age and older.… Read full story

COVID-19 Vaccination Associated With a Small, Temporary Increase in Menstrual Cycle Length, Suggests NIH-Funded Study

Women receiving one dose of a COVID-19 vaccine during a single menstrual cycle had an increase in cycle length of nearly one day, compared to unvaccinated women, according to a study funded by the National Institutes of Health. The increase in cycle length—a longer time between bleeding—was not associated with any change in the number of days of menses (days of bleeding).… Read full story